Related Experiment Video
Updated: Jun 23, 2026
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Emerging antiviral targets for influenza A virus
Robert M Krug1, James M Aramini
1Institute for Cellular and Molecular Biology, Section of Molecular Genetics and Microbiology, University of Texas at Austin, Austin, TX 78712, USA. rkrug@mail.utexas.edu
Trends in Pharmacological Sciences
|May 12, 2009
Summary
New research explores novel antiviral targets for influenza A viruses, including H5N1, due to increasing drug resistance. Structural studies guide the rational design of next-generation influenza antivirals.
Area of Science:
- Virology and Drug Discovery
- Structural Biology and Bioinformatics
Background:
- The threat of H5N1 influenza A virus pandemics necessitates novel antiviral development.
- Existing antivirals targeting M2 protein (adamantanes) and neuraminidase (zanamivir, oseltamivir) face resistance from seasonal and H5N1 strains.
- Emerging resistance highlights the urgent need for alternative therapeutic strategies against influenza A.
Purpose of the Study:
- To identify and characterize novel targets for influenza A virus antiviral drug development.
- To leverage functional and structural studies for the discovery of new therapeutic targets.
- To facilitate the rational design of novel antiviral agents against influenza A.
Main Methods:
- Functional analysis of key influenza A viral proteins, including NS1A, nucleoprotein, and viral polymerase.
- Elucidation of the structural basis for crucial viral protein functions.
- Integration of structural information with functional data for target identification and drug design.
Main Results:
- Identification of novel targets beyond M2 and neuraminidase, including NS1A protein, nucleoprotein, and viral polymerase.
- Structural insights into viral protein functions have revealed new avenues for antiviral intervention.
- Demonstration of how structural information aids in the rational design of drugs for both novel and existing targets.
Conclusions:
- Functional and structural studies are pivotal in discovering novel antiviral targets for influenza A viruses.
- Targeting viral proteins like NS1A, nucleoprotein, and polymerase offers promising strategies against resistant strains.
- Structural biology is crucial for the rational design of effective next-generation influenza antivirals.
More Related Videos
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...